Arterys, a San Francisco, California firm, won FDA clearance for its Arterys Oncology AI suite. The cleared software aids in finding lesions within CT images of the lungs (Lung AI) and in both CT and MRI when assessing the liver (Liver AI). It uses artificial intelligence methods to segment lesions and nodules, and in evaluations versus certified (Read more...)